The plan, to be carried out by national
malaria - control agencies in Cambodia and Thailand with support from various
research institutes, includes rapid and widespread treatment with ACTs, improved mosquito control, the distribution of long - lasting insecticide - impregnated bed nets, a ban on monotherapies in Cambodia (they are already rare in Thailand), and an information campaign.
The trial, which is still in progress, is the result of a collaboration between GSK, the PATH
Malaria Vaccine Initiative and a number of
research institutes around the world.